Barrett’s Esophagus — Patient Information

A clear guide for Valley Gastroenterology patients.

What is Barrett’s esophagus?

Barrett’s esophagus is a change in the lining of the lower esophagus caused by long‑standing acid reflux (GERD). Under the microscope, the normal lining is replaced with a different type of tissue (intestinal metaplasia). Barrett’s itself is not cancer, but it can increase the risk of developing esophageal cancer over time.

Who is at risk?

  • Long‑standing or frequent GERD symptoms
  • Age >50, male, central obesity, tobacco use
  • Family history of Barrett’s or esophageal cancer

Many people with Barrett’s have few or no symptoms—screening may be considered in higher‑risk patients with chronic GERD.

Symptoms & red flags

Common: heartburn, regurgitation, chest discomfort, trouble swallowing with solids

Call us promptly for: progressive dysphagia, unintentional weight loss, vomiting, bleeding (black/tarry stools), or persistent chest pain (seek urgent care/ER if severe or concerning for heart).

How is it diagnosed?

  • Upper endoscopy (EGD) with biopsies confirms Barrett’s and checks for dysplasia (precancerous changes).
  • If Barrett’s is confirmed, we assign a grade:
  • No dysplasia
  • Indefinite for dysplasia (often re‑check after optimizing acid control)
  • Low‑grade dysplasia (LGD)
  • High‑grade dysplasia (HGD)

Treatment & follow‑up

All patients

  • Acid control: usually a proton pump inhibitor (PPI) taken 30–60 minutes before breakfast (and before dinner if twice‑daily). We tailor dose/duration.
  • Lifestyle: weight management, elevate head of bed, avoid late meals, stop tobacco, limit triggers (varies by person).

If no dysplasia

  • Surveillance endoscopy at intervals recommended by your clinician to monitor for changes.

If low‑grade dysplasia

  • Options include endoscopic eradication therapy (commonly radiofrequency ablation [RFA] ± EMR for visible lesions) or close surveillance. We’ll review benefits and risks.

If high‑grade dysplasia or early cancer

  • Endoscopic eradication therapy (EMR/ESD and ablation) is often first‑line; surgery is rarely needed. Managed in coordination with our advanced endoscopy and oncology partners.

After successful eradication, ongoing surveillance is still needed to ensure durable control.

Living with Barrett’s

  • Take PPIs as directed; don’t stop without a plan
  • Maintain a healthy weight and active lifestyle
  • Limit alcohol; avoid tobacco/nicotine
  • Keep routine follow‑ups and surveillance on schedule

FAQs

Do PPIs prevent cancer? They reduce acid injury and may lower progression risk; surveillance is still important.

Will I need surgery? Most patients are managed with medications and endoscopic therapy. Surgery is uncommon and reserved for select cases.

Can reflux surgery (e.g., fundoplication) help? It can control reflux symptoms; decisions are individualized and do notreplace the need for surveillance.

Alaska‑specific note

We accommodate winter travel and weather‑related rescheduling without penalty. Telehealth is available for many visits; procedures require in‑person care.

Next steps

If you have chronic GERD or risk factors, schedule a consult to discuss whether screening endoscopy is appropriate. If you’ve already been diagnosed with Barrett’s, we’ll create a personalized surveillance and treatment plan.

Valley Gastroenterology

3190 E Meridian Park Loop, Suite 206

Wasilla, Alaska 99654

Phone: (907) 373-2544

Fax: (844) 689-4240

Web: ValleyGastroAK.com